Discover open access scientific publications

Comment on a Paper by Dupoiron Et Al. “A Phase III Randomized Controlled Study on the Efficacy and Improved Bowel Function of Prolonged-Release (PR) Oxycodone- Naloxone (Up to 160/80 Mg Daily) Versus Oxycodone PR”